These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 357990)

  • 1. Bromocriptine-induced inhibition of plasma dopamine, noradrenaline and adrenaline responses to LH-RF.
    Van Loon GR
    Nature; 1978 Sep; 275(5678):331-2. PubMed ID: 357990
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal plasma catecholamine responses in acromegalics.
    Van Loon GR
    J Clin Endocrinol Metab; 1979 May; 48(5):784-9. PubMed ID: 372207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bromocriptine on plasma catecholamines in normal subjects and prolactin-secreting tumor patients.
    Mancini AM; Barontini M; Armando I; Levin G; Kleiman A; Razumny J; Molocznik I
    J Endocrinol Invest; 1986 Jun; 9(3):223-6. PubMed ID: 3760461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of bromocriptine on plasma catecholamine concentrations in normal volunteers.
    Steardo L; Di Stasio E; Bonuso S; Maj M
    Eur J Clin Pharmacol; 1986; 29(6):713-5. PubMed ID: 3709615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A defect in catecholamine neurons in patients with prolactin-secreting pituitary adenoma.
    Van Loon GR
    Lancet; 1978 Oct; 2(8095):868-71. PubMed ID: 81414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bromocriptine on plasma catecholamines in normal men.
    Van Loon GR; Sole MJ; Bain J; Ruse JL
    Neuroendocrinology; 1979; 28(6):425-34. PubMed ID: 460538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine reduces plasma noradrenaline and 3,4-dihydroxyphenylacetic acid in normal and hypotensive subjects.
    Mercuro G; Rossetti ZL; Tocco L; Rivano CA; Cherchi A; Gessa GL
    Eur J Clin Pharmacol; 1985; 27(6):671-5. PubMed ID: 3987772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of adrenaline, noradrenaline and dopamine during forearm dynamic exercise.
    Hartling OJ; Kelbaek H; Gjørup T; Nielsen MD; Trap-Jensen J
    Clin Physiol; 1989 Aug; 9(4):399-404. PubMed ID: 2766683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release.
    Mannelli M; Delitala G; De Feo ML; Maggi M; Cuomo S; Piazzini M; Guazzelli R; Serio M
    J Clin Endocrinol Metab; 1984 Jul; 59(1):74-8. PubMed ID: 6725527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin-releasing action of LRF: a central catecholamine mediated event?
    Zhang YW; Yen SS
    Life Sci; 1984 Feb; 34(7):653-7. PubMed ID: 6366415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sampling site and conditions on plasma levels of noradrenaline, adrenaline and dopamine.
    Saar N; Jackson R; Bachmann A; Gordon R
    Prog Biochem Pharmacol; 1980; 17():90-7. PubMed ID: 7208507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat.
    Nagahama S; Chen YF; Oparil S
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H64-70. PubMed ID: 2861750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal catecholamine mechanisms in hypothalamic-pituitary disorders.
    Van Loon GR
    Metabolism; 1980 Nov; 29(11 Suppl 1):1198-202. PubMed ID: 7432178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Male sexual impotence. Report 15. Blood levels of adrenaline, noradrenaline, dopamine and serotonin in impotent male].
    Nakayama K; Matsuhashi M; Maki A; Takanami M; Murakami N; Fujio K; Miura K; Shirai M; Ando K
    Nihon Hinyokika Gakkai Zasshi; 1983 Sep; 74(9):1536-43. PubMed ID: 6676583
    [No Abstract]   [Full Text] [Related]  

  • 15. Oestrogen-induced hyperprolactinaemia in the rat: reduced concentrations of hypothalamic dopamine and the effects of bromocriptine.
    Smythe GA; Brandstater JF
    Aust J Biol Sci; 1980 Jun; 33(3):329-39. PubMed ID: 7425967
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in plasma catecholamine concentrations during endotracheal intubation.
    Russell WJ; Morris RG; Frewin DB; Drew SE
    Br J Anaesth; 1981 Aug; 53(8):837-9. PubMed ID: 7272146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adrenaline, noradrenaline and dopamine excretion and anxiety levels in surgical patients].
    Barham O; Puchalski Z
    Arch Psychol (Frankf); 1985; 137(4):291-5. PubMed ID: 4084046
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic control of sympathetic activity and blood pressure in haemodialysis patients.
    Sturani A; Degli Esposti E; De March A; Santoro A; Fuschini G; Zuccalà A; Chiarini C; Flamigni C; Zucchelli P
    Proc Eur Dial Transplant Assoc; 1983; 20():156-60. PubMed ID: 6657650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of bromocriptine to lower plasma catecholamines in normal men and women.
    Bybee DE; Wiesen M; Aronin N; Krieger DT; Frohman LA; Kopin IJ
    J Clin Endocrinol Metab; 1982 Mar; 54(3):648-50. PubMed ID: 6276434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma dopamine: source, regulation, and significance.
    Van Loon GR; Sole MJ
    Metabolism; 1980 Nov; 29(11 Suppl 1):1119-23. PubMed ID: 7001178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.